Survival-based bioinformatics analysis to identify hub long non-coding RNAs along with lncRNA-miRNA-mRNA network for potential diagnosis/prognosis of thyroid cancer

Abstract

Thyroid cancer (TC) is the most common endocrine cancer, accounting for 1.7% of all cancer cases. It has been reported that the existing approach to diagnosing TC is problematic. Therefore, it is essential to develop molecular biomarkers to improve the accuracy of the diagnosis. This study aimed to screen hub lncRNAs in the ceRNA network (ceRNET) connected to TC formation and progression based on the overall survival rate. In this study, first, RNA‐seq data from the GDC database were collected. A package called edgeR in R programming language was then used to obtain differentially expressed lncRNAs (DElncRNAs), miRNAs (DEmiRNAs), and mRNAs (DEmRNAs) in TC patients' samples compared to normal samples. Second, DEmRNAs were analyzed for their functional enrichment. Third, to identify RNAs associated with overall survival, the overall survival of these RNAs was analyzed using the Kaplan‐Meier plotter database to create a survival associated with the ceRNA network (survival‐related ceRNET). Next, the GeneMANIA plugin was used to construct a PPI network to better understand survival‐related DEmRNA interactions. The survival ceRNET was then visualized with the Cytoscape software, and hub genes, including hub lncRNAs and hub mRNAs, were identified using the CytoHubba plugin. We found 45 DElncRNAs, 28 DEmiRNAs, and 723 DEmRNAs among thyroid tumor tissue and non‐tumor tissue samples. According to KEGG, GO and DO analyses, 723 DEmRNAs were mainly enriched in cancer‐related pathways. Importantly, the results found that ten DElncRNAs, four DEmiRNAs, and 68 DEmRNAs are associated with overall survival. In this account, the PPI network was constructed for 68 survival‐related DEmRNAs, and ADAMTS9, DTX4, and CLDN10 were identified as hub genes. The ceRNET was created by combining six lncRNAs, 109 miRNAs, and 22 mRNAs related to survival using Cytoscape. in this network, ten hub RNAs were identified by the CytoHubba plugin, including mRNAs (CTXND1, XKRX, IGFBP2, ENTPD1, GALNT7, ADAMTS9) and lncRNAs (AC090673.1, AL162511.1, LINC02454, AL365259.1). This study suggests that three lncRNAs, including AL162511.1, AC090673.1, and AL365259.1, could be reliable diagnostic biomarkers for TC. The findings of this study provide a basis for future studies on the therapeutic potential of these lncRNAs.

Association of Skin Autofluorescence with Blood Glucose Levels in Children with Type 1 Diabetes Mellitus

“…A study by Mácsai and team examined the relationship between skin tissue SAF (measured with an AGEs Reader) and the presence of glucuronic acid, 3-indole sulfate, 3-hydroxybutyric acid, phenol sulfate, and pentosyranoside using desorption electrospray ionization mass spectrometry (DESI-MS) (41). It has been clearly demonstrated in many reports that these compounds are connected to diabetes and its complications, so they could be used to detect diabetes and its complications (42)(43)(44).…”

Circulating miRNAs as a Tool for Early Diagnosis of Endometrial Cancer—Implications for the Fertility-Sparing Process: Clinical, Biological, and Legal Aspects

“…Despite this organization should provide a certain redundancy able to confer robustness to mutations, it also allows a single alteration to hit multiple metabolic pathways at the same time, hence, the importance to identify and characterize ceRNET. These networks have been partially reported in neurodegenerative diseases [56,57] and in a few cancers such as lung adenocarcinoma [58], intrahepatic cholangiocellular carcinoma [59], hepatocellular carcinoma [60], glioma [61], thyroid cancer [62], and breast cancer [63,64]. However, for most cancer types, only single axes have been published so far.…”

Exosomal microRNAs in regulation of tumor cells resistance to apoptosis

“…Dysregulated genes or cellular mechanisms play a significant role in cancer development, particularly oncogenes and tumor suppressor genes [ 6 ]. Several “tumor suppressor genes" are activated and deactivated to regulate cancer initiation and progression [ 6 , 7 ]. As well as genetic mutation, chromosomal abrasion or alteration, such as addition or deletion, and changes to the cell cycle are important factors contributing to variation in established genetic mechanisms [ 8 ].…”